Therapeutic use of anti-TF-Antigen antibody

  • US 7,374,755 B2
  • Filed: 07/26/2005
  • Issued: 05/20/2008
  • Est. Priority Date: 07/26/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method for inhibiting in an individual metastasis of metastatic tumor cells, wherein the metastatic tumor cells express TF-Ag molecules, comprising administering to the individual an amount of monoclonal antibody JAA-F11 or an antigen binding fragment thereof sufficient to inhibit the metastasis of the metastatic tumor cells expressing the TF-Ag molecules, such that the metastasis of the cells expressing the TF-Ag molecules is inhibited.

View all claims

    Thank you for your feedback